ABBV-323 is an antagonist to CD40 being investigated to treat Crohn’s Disease.

Type of Molecule

Biologic

Target

CD40

Region

n/a

Potential Indication Product Type Phase (1, 2, 3, Submitted, Approved)
Crohn's Disease (CD) New Indication Phase 1